1. Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation
- Author
-
Herve Lemaitre, Jean-Luc Martinot, Frank Bellivier, Marie-Laure Paillère Martinot, Eric Artiges, Damien Ringuenet, Jean-Pascal Lefaucheur, Thierry Gallarda, André Galinowski, Adolescent psychopathology and Medicine, CHU Cochin [AP-HP], Hôpital Cochin [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
- Subjects
Male ,medicine.medical_treatment ,Clinical or Preclinical ,Stimulation ,Treatment response ,Imaging ,Depressive Disorder, Treatment-Resistant ,0302 clinical medicine ,medicine.diagnostic_test ,Brain Diseases, Metabolic ,Depression ,Brain ,Fluorodeoxyglucose ,Middle Aged ,Uncus ,Transcranial Magnetic Stimulation ,Magnetic Resonance Imaging ,Psychiatry and Mental health ,medicine.anatomical_structure ,[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,Cardiology ,Original Article ,Female ,Psychology ,psychological phenomena and processes ,Adult ,medicine.medical_specialty ,Uncinate fasciculus ,Amygdala ,behavioral disciplines and activities ,03 medical and health sciences ,Neuroimaging ,Double-Blind Method ,Internal medicine ,medicine ,Humans ,Unipolar ,Radionuclide Imaging ,Biological Psychiatry ,Aged ,Pharmacology ,Magnetic resonance imaging ,030227 psychiatry ,Transcranial magnetic stimulation ,Neuroanatomy ,nervous system ,Bipolar ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,Insula ,Neuroscience ,030217 neurology & neurosurgery ,Positron Emission Tomography - Abstract
International audience; Neuroimaging studies of patients with treatment-resistant depression (TRD) have reported abnormalities in frontal and temporal regions. We sought to determine whether metabolism in those regions might be related to response to repetitive transcranial magnetic stimulation (TMS) in patients with TRD. Magnetic resonance images and baseline resting-state cerebral glucose uptake index (gluMI) obtained using 18F-fluorodeoxyglucose positron emission tomography were analyzed in TRD patients who had participated in a double-blind, randomized, sham-controlled trial of prefrontal 10Hz-TMS. Among the patients randomized to active TMS, 17 responders, defined as having 50% depression score decrease, and 14 nonresponders were investigated for pre-stimulation glucose metabolism and compared with 39 healthy subjects using a voxel-based analysis. In nonresponders relative to responders, gluMI was lower in left lateral orbitofrontal cortex (OFC), and higher in left amygdala and uncinate fasciculus. OFC and amygdala gluMI negatively correlated in nonresponders, positively correlated in responders, and did not correlate in healthy subjects. Relative to healthy subjects, both responders and nonresponders displayed lower gluMI in right dorsolateral prefrontal (DLPFC), right anterior cingulate (ACC), and left ventrolateral prefrontal, cortices. Additionally, nonresponders had lower gluMI in left DLPFC, ACC, left and right insula, and higher gluMI in left amygdala and uncus. Hypometabolisms were partly explained by gray matter reductions, while hypermetabolisms were unrelated to structural changes. The findings suggest that different patterns of frontal-temporal limbic abnormalities may distinguish responders and nonresponders to prefrontal magnetic stimulation. Both preserved OFC volume and amygdala metabolism might precondition response to TMS.
- Published
- 2011
- Full Text
- View/download PDF